These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


327 related items for PubMed ID: 10521976

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Elevated levels of soluble interleukin-2 receptor in serum of patients with hematological or non-hematological malignancies.
    Nakase K, Tsuji K, Tamaki S, Tanigawa M, Ikeda T, Miyanishi E, Shiku H.
    Cancer Detect Prev; 2005; 29(3):256-9. PubMed ID: 15899555
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
    Shaarawy M, Darwish NA, Abdel-Aziz O.
    J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Serum soluble IL-2 receptor level in patients with sarcoidosis].
    Ina Y, Takada K, Noda M, Satou T, Hashiba H, Miyachi A, Ito S, Iijima N, Yamamoto M.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Mar; 29(3):316-21. PubMed ID: 2067152
    [Abstract] [Full Text] [Related]

  • 32. Serum cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as a prognostic tumor marker in patients with esophageal squamous cell carcinoma.
    Nabeya Y, Shimada H, Okazumi S, Matsubara H, Gunji Y, Suzuki T, Ochiai T.
    Cancer; 2002 Feb 15; 94(4):940-9. PubMed ID: 11920462
    [Abstract] [Full Text] [Related]

  • 33. Serum interleukin-12 and interleukin-18 levels as a tumor marker in patients with esophageal carcinoma.
    Tsuboi K, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Manda R, Fukuchi M, Kato H, Kuwano H.
    Cancer Lett; 2004 Mar 18; 205(2):207-14. PubMed ID: 15036653
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining.
    Gockel I, Domeyer M, Sgourakis GG, Schimanski CC, Moehler M, Kirkpatrick CJ, Lang H, Junginger T, Hansen T.
    J Surg Oncol; 2009 Sep 01; 100(3):191-8. PubMed ID: 19548259
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M, Kato H, Sano A, Tanaka N, Inose T, Kimura H, Sohda M, Nakajima M, Kuwano H.
    Ann Surg Oncol; 2009 Sep 01; 16(9):2494-501. PubMed ID: 19526206
    [Abstract] [Full Text] [Related]

  • 38. Plasma soluble interleukin-2 receptor (sIL-2R) levels in patients with acute leukemia.
    Moon Y, Kim Y, Kim M, Lim J, Kang CS, Kim WI, Shim SI, Chung NG, Park YH, Min WS, Han K.
    Ann Clin Lab Sci; 2004 Sep 01; 34(4):410-5. PubMed ID: 15648782
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.